nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—Hydrocortisone—atopic dermatitis	0.36	1	CrCtD
Drospirenone—NR3C2—Betamethasone—atopic dermatitis	0.0596	0.218	CbGbCtD
Drospirenone—NR3C2—Prednisolone—atopic dermatitis	0.0588	0.215	CbGbCtD
Drospirenone—PGR—Betamethasone—atopic dermatitis	0.0385	0.141	CbGbCtD
Drospirenone—NR3C2—Dexamethasone—atopic dermatitis	0.0347	0.127	CbGbCtD
Drospirenone—PGR—Dexamethasone—atopic dermatitis	0.0224	0.082	CbGbCtD
Drospirenone—BCHE—Triamcinolone—atopic dermatitis	0.021	0.077	CbGbCtD
Drospirenone—Flurandrenolide—Desonide—atopic dermatitis	0.0172	0.0514	CrCrCtD
Drospirenone—PTGS2—Triamcinolone—atopic dermatitis	0.0162	0.0592	CbGbCtD
Drospirenone—Testolactone—Desonide—atopic dermatitis	0.0151	0.0452	CrCrCtD
Drospirenone—PTGS2—Betamethasone—atopic dermatitis	0.0139	0.0508	CbGbCtD
Drospirenone—Flurandrenolide—Fluocinonide—atopic dermatitis	0.0137	0.0412	CrCrCtD
Drospirenone—Flurandrenolide—Fluocinolone Acetonide—atopic dermatitis	0.0134	0.04	CrCrCtD
Drospirenone—Eplerenone—Hydrocortisone—atopic dermatitis	0.0113	0.034	CrCrCtD
Drospirenone—Hydrocortisone—Desonide—atopic dermatitis	0.011	0.033	CrCrCtD
Drospirenone—Formestane—Hydrocortisone—atopic dermatitis	0.00949	0.0284	CrCrCtD
Drospirenone—Testolactone—Mometasone—atopic dermatitis	0.00937	0.0281	CrCrCtD
Drospirenone—Potassium Canrenoate—Hydrocortisone—atopic dermatitis	0.00859	0.0257	CrCrCtD
Drospirenone—Spironolactone—Hydrocortisone—atopic dermatitis	0.00859	0.0257	CrCrCtD
Drospirenone—PTGS2—Dexamethasone—atopic dermatitis	0.00808	0.0296	CbGbCtD
Drospirenone—Megestrol acetate—Hydrocortisone—atopic dermatitis	0.00786	0.0235	CrCrCtD
Drospirenone—Potassium Canrenoate—Prednisone—atopic dermatitis	0.0074	0.0222	CrCrCtD
Drospirenone—Medrysone—Hydrocortisone—atopic dermatitis	0.00725	0.0217	CrCrCtD
Drospirenone—Potassium Canrenoate—Prednisolone—atopic dermatitis	0.00722	0.0216	CrCrCtD
Drospirenone—Medroxyprogesterone Acetate—Hydrocortisone—atopic dermatitis	0.00699	0.0209	CrCrCtD
Drospirenone—Medrysone—Methylprednisolone—atopic dermatitis	0.00684	0.0205	CrCrCtD
Drospirenone—Hydrocortisone—Mometasone—atopic dermatitis	0.00684	0.0205	CrCrCtD
Drospirenone—Flurandrenolide—Hydrocortisone—atopic dermatitis	0.00674	0.0202	CrCrCtD
Drospirenone—Medroxyprogesterone Acetate—Methylprednisolone—atopic dermatitis	0.00659	0.0198	CrCrCtD
Drospirenone—Flurandrenolide—Methylprednisolone—atopic dermatitis	0.00636	0.0191	CrCrCtD
Drospirenone—Norethindrone—Hydrocortisone—atopic dermatitis	0.00631	0.0189	CrCrCtD
Drospirenone—Flurandrenolide—Dexamethasone—atopic dermatitis	0.00626	0.0188	CrCrCtD
Drospirenone—Flurandrenolide—Betamethasone—atopic dermatitis	0.00626	0.0188	CrCrCtD
Drospirenone—Cortisone acetate—Hydrocortisone—atopic dermatitis	0.00611	0.0183	CrCrCtD
Drospirenone—Medrysone—Prednisolone—atopic dermatitis	0.0061	0.0183	CrCrCtD
Drospirenone—Cortisone acetate—Methylprednisolone—atopic dermatitis	0.00577	0.0173	CrCrCtD
Drospirenone—Flurandrenolide—Prednisolone—atopic dermatitis	0.00567	0.017	CrCrCtD
Drospirenone—Testolactone—Methylprednisolone—atopic dermatitis	0.0056	0.0168	CrCrCtD
Drospirenone—Testolactone—Dexamethasone—atopic dermatitis	0.00551	0.0165	CrCrCtD
Drospirenone—Testolactone—Betamethasone—atopic dermatitis	0.00551	0.0165	CrCrCtD
Drospirenone—Testolactone—Triamcinolone—atopic dermatitis	0.00538	0.0161	CrCrCtD
Drospirenone—Progesterone—Hydrocortisone—atopic dermatitis	0.00531	0.0159	CrCrCtD
Drospirenone—Testosterone Propionate—Hydrocortisone—atopic dermatitis	0.00531	0.0159	CrCrCtD
Drospirenone—Cortisone acetate—Prednisone—atopic dermatitis	0.00527	0.0158	CrCrCtD
Drospirenone—Methyltestosterone—Hydrocortisone—atopic dermatitis	0.00518	0.0155	CrCrCtD
Drospirenone—Cortisone acetate—Prednisolone—atopic dermatitis	0.00514	0.0154	CrCrCtD
Drospirenone—Testolactone—Prednisone—atopic dermatitis	0.00511	0.0153	CrCrCtD
Drospirenone—Testolactone—Prednisolone—atopic dermatitis	0.00499	0.0149	CrCrCtD
Drospirenone—Testosterone—Hydrocortisone—atopic dermatitis	0.00461	0.0138	CrCrCtD
Drospirenone—Progesterone—Prednisolone—atopic dermatitis	0.00446	0.0134	CrCrCtD
Drospirenone—Methyltestosterone—Prednisone—atopic dermatitis	0.00446	0.0134	CrCrCtD
Drospirenone—Methyltestosterone—Prednisolone—atopic dermatitis	0.00435	0.013	CrCrCtD
Drospirenone—Hydrocortisone—Methylprednisolone—atopic dermatitis	0.00409	0.0122	CrCrCtD
Drospirenone—Hydrocortisone—Dexamethasone—atopic dermatitis	0.00402	0.012	CrCrCtD
Drospirenone—Hydrocortisone—Betamethasone—atopic dermatitis	0.00402	0.012	CrCrCtD
Drospirenone—Hydrocortisone—Triamcinolone—atopic dermatitis	0.00393	0.0118	CrCrCtD
Drospirenone—Testosterone—Prednisolone—atopic dermatitis	0.00388	0.0116	CrCrCtD
Drospirenone—Hydrocortisone—Prednisone—atopic dermatitis	0.00373	0.0112	CrCrCtD
Drospirenone—Hydrocortisone—Prednisolone—atopic dermatitis	0.00364	0.0109	CrCrCtD
Drospirenone—Infarction—Tacrolimus—atopic dermatitis	0.00149	0.0499	CcSEcCtD
Drospirenone—Cerebral infarction—Tacrolimus—atopic dermatitis	0.00127	0.0425	CcSEcCtD
Drospirenone—Uterine haemorrhage—Tacrolimus—atopic dermatitis	0.00119	0.0396	CcSEcCtD
Drospirenone—Infarction—Methylprednisolone—atopic dermatitis	0.000874	0.0292	CcSEcCtD
Drospirenone—Thrombosis—Tacrolimus—atopic dermatitis	0.000585	0.0196	CcSEcCtD
Drospirenone—Embolism venous—Prednisolone—atopic dermatitis	0.000524	0.0175	CcSEcCtD
Drospirenone—Embolism venous—Hydrocortisone—atopic dermatitis	0.000512	0.0171	CcSEcCtD
Drospirenone—Breast disorder—Pimecrolimus—atopic dermatitis	0.000499	0.0167	CcSEcCtD
Drospirenone—Embolism venous—Triamcinolone—atopic dermatitis	0.000482	0.0161	CcSEcCtD
Drospirenone—Embolism venous—Methylprednisolone—atopic dermatitis	0.000481	0.0161	CcSEcCtD
Drospirenone—Mental disorder—Desonide—atopic dermatitis	0.000474	0.0158	CcSEcCtD
Drospirenone—Embolism venous—Betamethasone—atopic dermatitis	0.000437	0.0146	CcSEcCtD
Drospirenone—Embolism venous—Dexamethasone—atopic dermatitis	0.000437	0.0146	CcSEcCtD
Drospirenone—Embolism—Prednisolone—atopic dermatitis	0.000412	0.0138	CcSEcCtD
Drospirenone—Embolism—Hydrocortisone—atopic dermatitis	0.000402	0.0135	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Desonide—atopic dermatitis	0.000398	0.0133	CcSEcCtD
Drospirenone—Embolism venous—Prednisone—atopic dermatitis	0.000381	0.0127	CcSEcCtD
Drospirenone—Embolism—Triamcinolone—atopic dermatitis	0.000379	0.0127	CcSEcCtD
Drospirenone—Embolism—Methylprednisolone—atopic dermatitis	0.000378	0.0126	CcSEcCtD
Drospirenone—Nervous system disorder—Desonide—atopic dermatitis	0.000377	0.0126	CcSEcCtD
Drospirenone—Skin disorder—Desonide—atopic dermatitis	0.000373	0.0125	CcSEcCtD
Drospirenone—Embolism—Dexamethasone—atopic dermatitis	0.000344	0.0115	CcSEcCtD
Drospirenone—Embolism—Betamethasone—atopic dermatitis	0.000344	0.0115	CcSEcCtD
Drospirenone—Depression—Loratadine—atopic dermatitis	0.000338	0.0113	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Fluocinonide—atopic dermatitis	0.000323	0.0108	CcSEcCtD
Drospirenone—Nervous system disorder—Fluocinonide—atopic dermatitis	0.000306	0.0102	CcSEcCtD
Drospirenone—Skin disorder—Fluocinonide—atopic dermatitis	0.000303	0.0101	CcSEcCtD
Drospirenone—Embolism—Prednisone—atopic dermatitis	0.000299	0.01	CcSEcCtD
Drospirenone—Affect lability—Tacrolimus—atopic dermatitis	0.000296	0.00989	CcSEcCtD
Drospirenone—Migraine—Tacrolimus—atopic dermatitis	0.000296	0.00989	CcSEcCtD
Drospirenone—PTGS2—Fluocinonide—Desonide—atopic dermatitis	0.000292	0.165	CbGdCrCtD
Drospirenone—Mood swings—Tacrolimus—atopic dermatitis	0.000285	0.00952	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Pimecrolimus—atopic dermatitis	0.000281	0.0094	CcSEcCtD
Drospirenone—Breast disorder—Tacrolimus—atopic dermatitis	0.000272	0.00908	CcSEcCtD
Drospirenone—Nervous system disorder—Pimecrolimus—atopic dermatitis	0.000266	0.0089	CcSEcCtD
Drospirenone—Skin disorder—Pimecrolimus—atopic dermatitis	0.000264	0.00882	CcSEcCtD
Drospirenone—Mental disorder—Fluocinolone Acetonide—atopic dermatitis	0.00024	0.00801	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.000234	0.00784	CcSEcCtD
Drospirenone—Depression—Tacrolimus—atopic dermatitis	0.000231	0.00772	CcSEcCtD
Drospirenone—Acute coronary syndrome—Tacrolimus—atopic dermatitis	0.000228	0.00763	CcSEcCtD
Drospirenone—Myocardial infarction—Tacrolimus—atopic dermatitis	0.000227	0.00759	CcSEcCtD
Drospirenone—PTGS2—Fluocinonide—Fluocinolone Acetonide—atopic dermatitis	0.000227	0.128	CbGdCrCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Loratadine—atopic dermatitis	0.000224	0.00749	CcSEcCtD
Drospirenone—Nervous system disorder—Loratadine—atopic dermatitis	0.000212	0.00709	CcSEcCtD
Drospirenone—Skin disorder—Loratadine—atopic dermatitis	0.00021	0.00702	CcSEcCtD
Drospirenone—Haemoglobin—Tacrolimus—atopic dermatitis	0.000209	0.00699	CcSEcCtD
Drospirenone—Haemorrhage—Tacrolimus—atopic dermatitis	0.000208	0.00695	CcSEcCtD
Drospirenone—Erythema multiforme—Tacrolimus—atopic dermatitis	0.000197	0.00657	CcSEcCtD
Drospirenone—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.000191	0.00637	CcSEcCtD
Drospirenone—Affect lability—Prednisolone—atopic dermatitis	0.000189	0.00632	CcSEcCtD
Drospirenone—Angiopathy—Tacrolimus—atopic dermatitis	0.000189	0.00631	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.000187	0.00624	CcSEcCtD
Drospirenone—Affect lability—Hydrocortisone—atopic dermatitis	0.000185	0.00617	CcSEcCtD
Drospirenone—Mental disorder—Tacrolimus—atopic dermatitis	0.000182	0.00609	CcSEcCtD
Drospirenone—Mood swings—Prednisolone—atopic dermatitis	0.000182	0.00608	CcSEcCtD
Drospirenone—PTGS2—Fluocinonide—Mometasone—atopic dermatitis	0.000181	0.102	CbGdCrCtD
Drospirenone—Mood swings—Hydrocortisone—atopic dermatitis	0.000178	0.00594	CcSEcCtD
Drospirenone—Affect lability—Triamcinolone—atopic dermatitis	0.000174	0.00581	CcSEcCtD
Drospirenone—Affect lability—Methylprednisolone—atopic dermatitis	0.000173	0.0058	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000168	0.00561	CcSEcCtD
Drospirenone—Mood swings—Triamcinolone—atopic dermatitis	0.000167	0.00559	CcSEcCtD
Drospirenone—Mood swings—Methylprednisolone—atopic dermatitis	0.000167	0.00558	CcSEcCtD
Drospirenone—Nausea—Dimenhydrinate—atopic dermatitis	0.000167	0.00558	CcSEcCtD
Drospirenone—Nausea—Diphenhydramine—atopic dermatitis	0.000167	0.00558	CcSEcCtD
Drospirenone—NR3C2—ACE Inhibitor Pathway—CMA1—atopic dermatitis	0.000164	0.191	CbGpPWpGaD
Drospirenone—Nausea—Pimecrolimus—atopic dermatitis	0.000161	0.00539	CcSEcCtD
Drospirenone—Breast disorder—Methylprednisolone—atopic dermatitis	0.000159	0.00532	CcSEcCtD
Drospirenone—Migraine—Dexamethasone—atopic dermatitis	0.000158	0.00527	CcSEcCtD
Drospirenone—Affect lability—Betamethasone—atopic dermatitis	0.000158	0.00527	CcSEcCtD
Drospirenone—Migraine—Betamethasone—atopic dermatitis	0.000158	0.00527	CcSEcCtD
Drospirenone—Affect lability—Dexamethasone—atopic dermatitis	0.000158	0.00527	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000153	0.00512	CcSEcCtD
Drospirenone—Mood swings—Dexamethasone—atopic dermatitis	0.000152	0.00507	CcSEcCtD
Drospirenone—Mood swings—Betamethasone—atopic dermatitis	0.000152	0.00507	CcSEcCtD
Drospirenone—Acute coronary syndrome—Prednisolone—atopic dermatitis	0.000146	0.00488	CcSEcCtD
Drospirenone—Myocardial infarction—Prednisolone—atopic dermatitis	0.000145	0.00485	CcSEcCtD
Drospirenone—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000145	0.00484	CcSEcCtD
Drospirenone—Skin disorder—Tacrolimus—atopic dermatitis	0.000144	0.0048	CcSEcCtD
Drospirenone—Acute coronary syndrome—Hydrocortisone—atopic dermatitis	0.000142	0.00476	CcSEcCtD
Drospirenone—Myocardial infarction—Hydrocortisone—atopic dermatitis	0.000142	0.00473	CcSEcCtD
Drospirenone—PTGS2—Fluticasone Propionate—Fluocinonide—atopic dermatitis	0.000141	0.0797	CbGdCrCtD
Drospirenone—Affect lability—Prednisone—atopic dermatitis	0.000137	0.00459	CcSEcCtD
Drospirenone—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—atopic dermatitis	0.000137	0.0774	CbGdCrCtD
Drospirenone—Acute coronary syndrome—Triamcinolone—atopic dermatitis	0.000134	0.00448	CcSEcCtD
Drospirenone—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	0.000134	0.00447	CcSEcCtD
Drospirenone—Haemoglobin—Prednisolone—atopic dermatitis	0.000134	0.00446	CcSEcCtD
Drospirenone—Myocardial infarction—Triamcinolone—atopic dermatitis	0.000133	0.00446	CcSEcCtD
Drospirenone—Myocardial infarction—Methylprednisolone—atopic dermatitis	0.000133	0.00445	CcSEcCtD
Drospirenone—Haemorrhage—Prednisolone—atopic dermatitis	0.000133	0.00444	CcSEcCtD
Drospirenone—Mood swings—Prednisone—atopic dermatitis	0.000132	0.00442	CcSEcCtD
Drospirenone—Haemoglobin—Hydrocortisone—atopic dermatitis	0.00013	0.00436	CcSEcCtD
Drospirenone—Haemorrhage—Hydrocortisone—atopic dermatitis	0.00013	0.00434	CcSEcCtD
Drospirenone—Nausea—Loratadine—atopic dermatitis	0.000128	0.00429	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000128	0.00426	CcSEcCtD
Drospirenone—Haemoglobin—Triamcinolone—atopic dermatitis	0.000123	0.0041	CcSEcCtD
Drospirenone—Haemoglobin—Methylprednisolone—atopic dermatitis	0.000123	0.00409	CcSEcCtD
Drospirenone—Haemorrhage—Triamcinolone—atopic dermatitis	0.000122	0.00408	CcSEcCtD
Drospirenone—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000122	0.00407	CcSEcCtD
Drospirenone—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.000122	0.00407	CcSEcCtD
Drospirenone—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.000122	0.00407	CcSEcCtD
Drospirenone—Myocardial infarction—Dexamethasone—atopic dermatitis	0.000121	0.00404	CcSEcCtD
Drospirenone—Myocardial infarction—Betamethasone—atopic dermatitis	0.000121	0.00404	CcSEcCtD
Drospirenone—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000115	0.00386	CcSEcCtD
Drospirenone—Mental disorder—Hydrocortisone—atopic dermatitis	0.000114	0.0038	CcSEcCtD
Drospirenone—Haemoglobin—Betamethasone—atopic dermatitis	0.000111	0.00372	CcSEcCtD
Drospirenone—Haemoglobin—Dexamethasone—atopic dermatitis	0.000111	0.00372	CcSEcCtD
Drospirenone—Haemorrhage—Dexamethasone—atopic dermatitis	0.000111	0.0037	CcSEcCtD
Drospirenone—Haemorrhage—Betamethasone—atopic dermatitis	0.000111	0.0037	CcSEcCtD
Drospirenone—Angiopathy—Methylprednisolone—atopic dermatitis	0.000111	0.0037	CcSEcCtD
Drospirenone—Nausea—Mometasone—atopic dermatitis	0.00011	0.00369	CcSEcCtD
Drospirenone—PTGS2—Fluticasone Propionate—Mometasone—atopic dermatitis	0.000109	0.0618	CbGdCrCtD
Drospirenone—PTGS2—Fluocinonide—Methylprednisolone—atopic dermatitis	0.000108	0.0612	CbGdCrCtD
Drospirenone—Depression—Prednisone—atopic dermatitis	0.000107	0.00358	CcSEcCtD
Drospirenone—Mental disorder—Methylprednisolone—atopic dermatitis	0.000107	0.00357	CcSEcCtD
Drospirenone—PTGS2—Fluocinonide—Dexamethasone—atopic dermatitis	0.000106	0.0602	CbGdCrCtD
Drospirenone—PTGS2—Fluocinonide—Betamethasone—atopic dermatitis	0.000106	0.0602	CbGdCrCtD
Drospirenone—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000106	0.00354	CcSEcCtD
Drospirenone—Myocardial infarction—Prednisone—atopic dermatitis	0.000105	0.00352	CcSEcCtD
Drospirenone—PTGS2—Fluocinonide—Triamcinolone—atopic dermatitis	0.000104	0.0588	CbGdCrCtD
Drospirenone—Angiopathy—Dexamethasone—atopic dermatitis	0.000101	0.00336	CcSEcCtD
Drospirenone—Angiopathy—Betamethasone—atopic dermatitis	0.000101	0.00336	CcSEcCtD
Drospirenone—Haemoglobin—Prednisone—atopic dermatitis	9.7e-05	0.00324	CcSEcCtD
Drospirenone—Haemorrhage—Prednisone—atopic dermatitis	9.65e-05	0.00323	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	9.55e-05	0.00319	CcSEcCtD
Drospirenone—Nervous system disorder—Hydrocortisone—atopic dermatitis	9.04e-05	0.00302	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	8.97e-05	0.003	CcSEcCtD
Drospirenone—Skin disorder—Hydrocortisone—atopic dermatitis	8.95e-05	0.00299	CcSEcCtD
Drospirenone—Nausea—Tacrolimus—atopic dermatitis	8.78e-05	0.00293	CcSEcCtD
Drospirenone—Angiopathy—Prednisone—atopic dermatitis	8.76e-05	0.00293	CcSEcCtD
Drospirenone—Nervous system disorder—Methylprednisolone—atopic dermatitis	8.49e-05	0.00284	CcSEcCtD
Drospirenone—Mental disorder—Prednisone—atopic dermatitis	8.46e-05	0.00283	CcSEcCtD
Drospirenone—Skin disorder—Methylprednisolone—atopic dermatitis	8.41e-05	0.00281	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	7.96e-05	0.00266	CcSEcCtD
Drospirenone—Nervous system disorder—Betamethasone—atopic dermatitis	7.72e-05	0.00258	CcSEcCtD
Drospirenone—Nervous system disorder—Dexamethasone—atopic dermatitis	7.72e-05	0.00258	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	7.1e-05	0.00237	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Betamethasone—atopic dermatitis	6.8e-05	0.00227	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	6.8e-05	0.00227	CcSEcCtD
Drospirenone—Nervous system disorder—Prednisone—atopic dermatitis	6.73e-05	0.00225	CcSEcCtD
Drospirenone—Skin disorder—Prednisone—atopic dermatitis	6.66e-05	0.00223	CcSEcCtD
Drospirenone—PTGS2—Fluticasone Propionate—Methylprednisolone—atopic dermatitis	6.53e-05	0.0369	CbGdCrCtD
Drospirenone—PTGS2—Fluticasone Propionate—Betamethasone—atopic dermatitis	6.42e-05	0.0363	CbGdCrCtD
Drospirenone—PTGS2—Fluticasone Propionate—Dexamethasone—atopic dermatitis	6.42e-05	0.0363	CbGdCrCtD
Drospirenone—PTGS2—Fluticasone Propionate—Triamcinolone—atopic dermatitis	6.28e-05	0.0355	CbGdCrCtD
Drospirenone—PGR—Cellular roles of Anthrax toxin—CASP1—atopic dermatitis	5.79e-05	0.0676	CbGpPWpGaD
Drospirenone—Nausea—Prednisolone—atopic dermatitis	5.61e-05	0.00187	CcSEcCtD
Drospirenone—Nausea—Hydrocortisone—atopic dermatitis	5.47e-05	0.00183	CcSEcCtD
Drospirenone—Nausea—Triamcinolone—atopic dermatitis	5.16e-05	0.00172	CcSEcCtD
Drospirenone—Nausea—Methylprednisolone—atopic dermatitis	5.14e-05	0.00172	CcSEcCtD
Drospirenone—Nausea—Betamethasone—atopic dermatitis	4.68e-05	0.00156	CcSEcCtD
Drospirenone—Nausea—Dexamethasone—atopic dermatitis	4.68e-05	0.00156	CcSEcCtD
Drospirenone—Nausea—Prednisone—atopic dermatitis	4.07e-05	0.00136	CcSEcCtD
Drospirenone—PGR—Cellular roles of Anthrax toxin—IL18—atopic dermatitis	4.03e-05	0.047	CbGpPWpGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CABIN1—atopic dermatitis	3.77e-05	0.044	CbGpPWpGaD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	2.92e-05	0.034	CbGpPWpGaD
Drospirenone—PGR—Nuclear Receptors—PPARA—atopic dermatitis	2.25e-05	0.0262	CbGpPWpGaD
Drospirenone—PGR—Cellular roles of Anthrax toxin—IL1B—atopic dermatitis	2.11e-05	0.0246	CbGpPWpGaD
Drospirenone—PGR—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	1.78e-05	0.0207	CbGpPWpGaD
Drospirenone—BCHE—Peptide hormone metabolism—CMA1—atopic dermatitis	1.76e-05	0.0205	CbGpPWpGaD
Drospirenone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—atopic dermatitis	1.74e-05	0.0203	CbGpPWpGaD
Drospirenone—AR—Nuclear Receptors—PPARA—atopic dermatitis	1.71e-05	0.02	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—atopic dermatitis	1.7e-05	0.0199	CbGpPWpGaD
Drospirenone—PGR—Cellular roles of Anthrax toxin—TNF—atopic dermatitis	1.53e-05	0.0178	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—IL5—atopic dermatitis	1.48e-05	0.0172	CbGpPWpGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—atopic dermatitis	1.37e-05	0.016	CbGpPWpGaD
Drospirenone—AR—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	1.35e-05	0.0158	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—atopic dermatitis	1.25e-05	0.0146	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—CXCL8—atopic dermatitis	1.08e-05	0.0126	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—atopic dermatitis	1.08e-05	0.0126	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL13—atopic dermatitis	1.02e-05	0.0119	CbGpPWpGaD
Drospirenone—AR—Notch-mediated HES/HEY network—CD4—atopic dermatitis	9.47e-06	0.011	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	9.39e-06	0.011	CbGpPWpGaD
Drospirenone—AR—Coregulation of Androgen receptor activity—CASP8—atopic dermatitis	9.36e-06	0.0109	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—atopic dermatitis	8.87e-06	0.0104	CbGpPWpGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—atopic dermatitis	8.29e-06	0.00968	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—TNF—atopic dermatitis	7.53e-06	0.00878	CbGpPWpGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—atopic dermatitis	7.37e-06	0.0086	CbGpPWpGaD
Drospirenone—AR—Regulation of Androgen receptor activity—MAPK8—atopic dermatitis	7.28e-06	0.0085	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	6.69e-06	0.0078	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL10—atopic dermatitis	6.38e-06	0.00745	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—IL6—atopic dermatitis	6.08e-06	0.00709	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—atopic dermatitis	5.96e-06	0.00695	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—NGF—atopic dermatitis	5.94e-06	0.00692	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	5.69e-06	0.00664	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—atopic dermatitis	5.36e-06	0.00626	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CXCL10—atopic dermatitis	5.35e-06	0.00624	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	5.06e-06	0.0059	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—PPARA—atopic dermatitis	5.04e-06	0.00588	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—atopic dermatitis	4.99e-06	0.00582	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—BDNF—atopic dermatitis	4.81e-06	0.00561	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—atopic dermatitis	4.77e-06	0.00556	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—CASP8—atopic dermatitis	4.53e-06	0.00529	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL4—atopic dermatitis	4.46e-06	0.00521	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—GLB1—atopic dermatitis	4.37e-06	0.0051	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	4.16e-06	0.00486	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	3.76e-06	0.00438	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FCER2—atopic dermatitis	3.75e-06	0.00437	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	3.71e-06	0.00433	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	3.49e-06	0.00407	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.48e-06	0.00406	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL22—atopic dermatitis	3.48e-06	0.00406	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atopic dermatitis	3.47e-06	0.00405	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CD4—atopic dermatitis	3.42e-06	0.00399	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IFNG—atopic dermatitis	3.41e-06	0.00398	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	3.35e-06	0.00391	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CMA1—atopic dermatitis	3.31e-06	0.00387	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	3.27e-06	0.00382	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL27—atopic dermatitis	3.1e-06	0.00362	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—PPARA—atopic dermatitis	3.07e-06	0.00358	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IL1B—atopic dermatitis	3.04e-06	0.00355	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL17—atopic dermatitis	2.78e-06	0.00325	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IFNG—atopic dermatitis	2.7e-06	0.00315	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—IL6—atopic dermatitis	2.63e-06	0.00307	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.61e-06	0.00305	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CXCL8—atopic dermatitis	2.51e-06	0.00293	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KIF3A—atopic dermatitis	2.48e-06	0.00289	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—TNF—atopic dermatitis	2.43e-06	0.00283	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—PPARA—atopic dermatitis	2.43e-06	0.00283	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL1B—atopic dermatitis	2.41e-06	0.00281	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL2—atopic dermatitis	2.4e-06	0.0028	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.39e-06	0.00279	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—PPARA—atopic dermatitis	2.34e-06	0.00273	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GLB1—atopic dermatitis	2.25e-06	0.00263	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CMA1—atopic dermatitis	2.24e-06	0.00262	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL11—atopic dermatitis	2.24e-06	0.00262	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—TNF—atopic dermatitis	2.21e-06	0.00258	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ADSL—atopic dermatitis	2.16e-06	0.00252	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.16e-06	0.00252	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—STAT6—atopic dermatitis	2.11e-06	0.00246	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	2.07e-06	0.00241	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.96e-06	0.00229	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GLB1—atopic dermatitis	1.85e-06	0.00216	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCR3—atopic dermatitis	1.83e-06	0.00213	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IL6—atopic dermatitis	1.78e-06	0.00208	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TNF—atopic dermatitis	1.75e-06	0.00204	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.64e-06	0.00192	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NPS—atopic dermatitis	1.63e-06	0.0019	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TAC1—atopic dermatitis	1.63e-06	0.0019	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCR3—atopic dermatitis	1.6e-06	0.00187	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GLB1—atopic dermatitis	1.55e-06	0.00181	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL5—atopic dermatitis	1.52e-06	0.00177	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.5e-06	0.00175	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ADSL—atopic dermatitis	1.49e-06	0.00173	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PPARA—atopic dermatitis	1.48e-06	0.00172	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL6—atopic dermatitis	1.41e-06	0.00164	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL10—atopic dermatitis	1.29e-06	0.00151	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SLC11A1—atopic dermatitis	1.24e-06	0.00145	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.19e-06	0.00139	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.13e-06	0.00132	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PPARA—atopic dermatitis	1.13e-06	0.00131	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL5—atopic dermatitis	1.11e-06	0.0013	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NGF—atopic dermatitis	1.03e-06	0.0012	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCR5—atopic dermatitis	1e-06	0.00117	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CXCL8—atopic dermatitis	8.95e-07	0.00104	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NFKBIA—atopic dermatitis	8.5e-07	0.000991	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPARA—atopic dermatitis	7.31e-07	0.000853	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CCR5—atopic dermatitis	6.27e-07	0.000731	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL8—atopic dermatitis	6.06e-07	0.000707	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL2—atopic dermatitis	5.79e-07	0.000676	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MAPK8—atopic dermatitis	5.33e-07	0.000622	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPARA—atopic dermatitis	5.03e-07	0.000587	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CD4—atopic dermatitis	3.94e-07	0.000459	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6—atopic dermatitis	3.4e-07	0.000397	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6—atopic dermatitis	2.13e-07	0.000248	CbGpPWpGaD
